Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Open accessThe DOI matches its Crossref record; 773 of the 831 references it cites were found in a registry or an index; 177 of the 559 sources its claims cite were checked for support.
Abstract
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders affecting cortisol biosynthesis. Reduced activity of an enzyme required for cortisol production leads to chronic overstimulation of the adrenal cortex and accumulation of precursors proximal to the blocked enzymatic step. The most common form of CAH is caused by steroid 21-hydroxylase deficiency due to mutations in CYP21A2. Since the last publication summarizing CAH in Endocrine Reviews in 2000, there have been numerous new developments. These include more detailed understanding of steroidogenic pathways, refinements in neonatal screening, improved diagnostic measurements utilizing chromatography and mass spectrometry coupled with steroid profiling, and improved genotyping methods. Clinical trials of alternative medications and modes of delivery have been recently completed or are under way. Genetic and cell-based treatments are being explored. A large body of data concerning long-term outcomes in patients affected by CAH, including psychosexual well-being, has been enhanced by the establishment of disease registries. This review provides the reader with current insights in CAH with special attention to these new developments.
Overview
CoChat Summary
TL;DR
This review summarizes current understanding of congenital adrenal hyperplasia (CAH), predominantly 21-hydroxylase deficiency (21OHD), covering steroidogenesis, genetics, diagnosis, management, and long-term outcomes. It emphasizes a phenotypic continuum, newer biomarkers and therapies, and persistent evidence gaps in treatment and surgical care.
Key findings
- 21OHD accounts for approximately 90–99% of CAH; classic CAH incidence is about 1 in 14,000 to 18,000 by newborn screening, while nonclassic (NC) CAH is estimated at ~1 in 200 in the Caucasian population.
- Genotype correlates with the less severely impaired CYP21A2 allele: 96% of individuals with two Group 0 alleles have salt-wasting CAH, whereas 97% of those with at least one Group C allele have NC CAH; residual enzyme activity is ~1–5% in simple virilizing and ~20–50% in NC CAH.
- Long-term sequelae include testicular adrenal rest tumors (TARTs) in males (reported prevalence 14–86%, average 25% in adolescents and 46% in men), adrenal masses in ~20–30% of adults, and increased mortality; adrenal crises caused 42% of deaths in a Swedish cohort, with mean age at death 54.8 years versus 72.8 years in controls.
- Newer concepts include 11-oxo-androgens such as 11-ketotestosterone as biomarkers, the backdoor pathway to dihydrotestosterone, and novel therapies (CRHR1 antagonists, abiraterone, modified-release hydrocortisone, gene/cell-based approaches), though many lack peer-reviewed long-term outcomes.
Methods
- Narrative, multi-authored review resulting from a planned European CAH Symposium postponed due to the COVID-19 pandemic; it covers pathophysiology, diagnostics, management, long-term sequelae, developing-country challenges, and future directions.
- Evidence base is a synthesis of published literature, clinical guidelines (including the 2018 Endocrine Society guideline), registries, observational studies, meta-analyses, and clinical trials; no primary patient cohort or systematic search is described.
- Main analysis is narrative synthesis, with tables and figures summarizing incidence, allele frequencies, treatment dosing, monitoring, and prenatal dexamethasone outcomes.
Limitations
- Stated: there are no large-scale prospective randomized trials for any therapies discussed; evidence is generally low or moderate quality and rests partly on expert opinion, values, and preferences.
- Stated: no evidence-based guidelines for surgical management exist, and there are no studies comparing different feminizing surgery techniques or early versus late surgery; genotype-phenotype correlations are strong but not absolute, and many neuroimaging studies are hindered by small sample size.
- Evident: as a narrative review, it does not report a systematic search strategy, formal risk-of-bias assessment, or quantitative synthesis; conclusions depend on the cited literature and expert consensus.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
86 Valid · 78 Not valid · 186 Not checked · 76 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Supraphysiological dosages of glucocorticoids similar to those used to treat classic CAH patients may be necessary to suppress adrenal androgen production (426).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Growth
What the sources say
- Disputedcites [426] Livadas, 2019, Management of the female with non-classical congenital adrenal hyperplasia (NCCAH): a patient-oriented approach, Front Endocrinol (Lausanne). sourceExperimental — accuracy not yet measured
In “NCCAH Management From the First Manifestation to the Adult Life” (page unavailable), the paper says glucocorticoids are generally given at replacement, not pharmacological, doses to decrease adrenal androgen production. Its “Management During Childhood” section adds that very high doses are needed to suppress 17-OHP and progesterone, not that supraphysiological doses are necessary to suppress adrenal androgens. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Females do outnumber males in some(12,240,241) although not all (242) retrospective studies in which CAH was clinically diagnosed without neonatal screening.”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Table 7
What the sources say
- Not checked — no full text of the sourcecites [12] Dumic, 2009, Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia between 1995 and 2006, Horm Res. source
- Not checked — no full text of the sourcecites [240] Hird, 2014, No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening, Arch Dis Child. source
- Disputedcites [241] Riedl, 2019, Genotype/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients, Endocr Connect. sourceExperimental — accuracy not yet measured
Citation (242) is attached to “not all,” offering this study as an example of a retrospectively studied, clinically diagnosed prescreening group without a female majority. The Results (Eligible patients; page unavailable) say the opposite: females made up 64% of the prescreening group. The approximately equal sex distribution was in the screened group, which does not fit that clause. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“A single-dose, fixed-sequence study of 8 women given 300 or 600 mg of the CRHR1 antagonist NBI77860 at 2200 (10 PM) showed significant reductions in ACTH and 17OHP over the ensuing 16 hours relative to a control period during which glucocorticoid treatment was withheld (498).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > D. New medical strategies (Figure 5)
What the sources say
- Disputedcites [498] Sanders, 2018, Melanocortin 2 receptor antagonists in canine pituitary-dependent hypercortisolism: in vitro studies, Vet Res Commun. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 2 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plainstates a causen = 8- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Excessive nighttime glucocorticoid administration has potential adverse metabolic consequences (371,382).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Table 7
What the sources say
- Not checked — no full text of the sourcecites [371] Han, 2013, Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia, Clin Endocrinol (Oxf). source
- Partly supportedcites [382] Whitaker, 2014, An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure, Clin Endocrinol (Oxf). sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says cortisol is normally low around midnight and that loss of its rhythm is associated with insulin resistance. It also suggests physiological replacement may help metabolic homeostasis. These passages support a potential metabolic concern, but the paper does not specifically state that excessive nighttime glucocorticoid administration has adverse metabolic consequences. (LLM, conf=0.82)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Low expression of CYP21A2 during the second trimester partially explains the high incidence of false-positives in newborn screens for CAH in premature infants (see section IV.A)(159).”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Pattern of CYP21A2 expression
What the sources say
- Could not verifycites [159] Zhou, 1997, Steroid 21-hydroxylase expression and activity in human lymphocytes, Mol Cell Endocrinol. sourceExperimental — accuracy not yet measured
Section 3.1 reports CYP21 expression in cultured lymphoid cells, including cells from CAH patients, but does not examine expression during the second trimester. Searches for premature infants, newborn screening, and false positives found no passage addressing the proposed explanation. (LLM, conf=0.76)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
207 more claims · 72 with their cited sources checked
Create a free account to see all 426 claims and to verify the 50 references still open.
- It may state two separate claims as one. 172
- Probably not a substantial claim. 64
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been reported that heterozygous TNXB mutations may be associated with the mild joint hypermobility form of EDS [1, 15] and that up to 10% of classic SW-CAH patients harboring in compound heterozygosity a TNXB/CYP21A2 genotype tend to demonstrate an extended phenotype termed CAH-X syndrome [1, 31, 32] (Fig. 2).”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been reported that heterozygous TNXB mutations may be associated with the mild joint hypermobility form of EDS [1, 15] and that up to 10% of classic SW-CAH patients harboring in compound heterozygosity a TNXB/CYP21A2 genotype tend to demonstrate an extended phenotype termed CAH-X syndrome [1, 31, 32] (Fig. 2).”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several reports in European, Mediterranean, Middle Eastern, and Chinese populations confirmed a high frequency of the pathogenic IVS2-13A/C > G and found it to comprise 20 to 25% of the CYP21A2 mutant alleles and to translate to the most severe SW forms of the disease when inherited in homozygosity [1, 4, 27, 39–43].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“When combined with complementary methods such MLPA for copy number analysis, it provides nearly complete diagnostic coverage, identifying up to 98-99% of classical pathogenic alleles in most populations (1, 16, 76).”
From Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques (2026) · cites this paper as [76]
In the citing paper
“Although CAH is rare, the most common form is caused by steroid 21-hydroxylase deficiency (21-OHD) and is an autosomal-recessive disorder of adrenal steroidogenesis that results from CYP21A2 mutations.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [1]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Sodium chloride supplements 1-2 g (17-24 mEq/day) in infancy”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > Graphical Abstract
Reported 24 · recomputed 34
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“A recent meta-analysis of 48 CAH cases, 34 (71%) described symptomatic improvement after bilateral adrenalectomy but with 34 cases (10%) reporting short-term and 13 cases (27%) long-term adverse outcomes”
§ Congenital adrenal hyperplasia -current insights in pathophysiology, diagnostics and management > D. New medical strategies (Figure 5)
Reported 10 · recomputed 70.833333
Citations
Cites
Items 401–600 of 773
Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Stimson, R. H., Rees, D. A., Krone, N., Willis, D. S., Conway, G. S., Arlt, W., Walker, B. R., Ross, R. J., & (CaHASE), U. K. C. A. H. A. S. E. (2013) · Clinical Endocrinology · doi:10.1111/cen.12045 · Cited by 70
Self-citationAlternative pathway androgen biosynthesis and human fetal female virilization
Reisch, N., Taylor, A. E., Nogueira, E. F., Asby, D. J., Dhir, V., Berry, A., Krone, N., Auchus, R. J., Shackleton, C. H. L., Hanley, N. A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906623116 · Cited by 70
Self-citationWudy, S. A., Wachter, U. A., Homoki, J., & Teller, W. M. (1995) · Pediatric Research · doi:10.1203/00006450-199507000-00013 · Cited by 69
Self-citationInforming parents about positive newborn screen results: Parents' recommendations
Salm, N., Yetter, E., & Tluczek, A. (2012) · Journal of Child Health Care · doi:10.1177/1367493512443906 · Cited by 69
Gonadal function in adult male patients with congenital adrenal hyperplasia
Engels, M., Gehrmann, K., Falhammar, H., Webb, E. A., Nordenström, A., Sweep, F. C., Span, P. N., van Herwaarden, A. E., Rohayem, J., Richter-Unruh, A., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0862 · Cited by 69
Self-citationRiedl, S., Röhl, F.-W., Bonfig, W., Brämswig, J., Richter-Unruh, A., Fricke-Otto, S., Bettendorf, M., Riepe, F., Kriegshäuser, G., Schönau, E., et al. (2019) · Endocrine Connections · doi:10.1530/ec-18-0281 · Cited by 69
Career Barriers Experienced by People with Chronic Illness: A U.S. Study
Beatty, J. E. (2011) · Employee Responsibilities and Rights Journal · doi:10.1007/s10672-011-9177-z · Cited by 69
Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia
Morissette, R., Chen, W., Perritt, A. F., Dreiling, J. L., Arai, A. E., Sachdev, V., Hannoush, H., Mallappa, A., Xu, Z., McDonnell, N. B., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2232 · Cited by 68
Self-citationBarbat, B., Bogyo, A., Raux-Demay, M.-C., Kuttenn, F., Boué, J., Simon-Bouy, B., Serre, J.-L., Boué, A., & Mornet, E. (1995) · Human Mutation · doi:10.1002/humu.1380050205 · Cited by 68
Swart, A. C., & Storbeck, K.-H. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.009 · Cited by 68
Current practice in feminizing surgery for congenital adrenal hyperplasia; a specialist survey
Yankovic, F., Cherian, A., Steven, L., Mathur, A., & Cuckow, P. (2013) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2013.03.013 · Cited by 68
Abiraterone acetate treatment lowers 11-oxygenated androgens
Wright, C., O’Day, P., Alyamani, M., Sharifi, N., & Auchus, R. J. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0905 · Cited by 68
Self-citationMarra, A. M., Improda, N., Capalbo, D., Salzano, A., Arcopinto, M., De Paulis, A., Alessio, M., Lenzi, A., Isidori, A. M., Cittadini, A., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1805 · Cited by 67
Zainuddin, A. A., Grover, S. R., Shamsuddin, K., & Mahdy, Z. A. (2013) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2012.08.004 · Cited by 67
Kleinle, S., Lang, R., Fischer, G. F., Vierhapper, H., Waldhauser, F., Födinger, M., & Baumgartner-Parzer, S. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0487 · Cited by 67
Hoepffner, W., Schulze, E., Bennek, J., Keller, E., & Willgerodt, H. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.024 · Cited by 67
Nass, R., Heier, L., Moshang, T., Oberfield, S., George, A., New, M. I., & Speiser, P. W. (1997) · Journal of Child Neurology · doi:10.1177/088307389701200306 · Cited by 67
Self-citationPrenatal treatment of congenital adrenal hyperplasia
Lajic, S., Nordenstrom, A., Ritzen, E., & Wedell, A. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u063 · Cited by 67
Sex-dimorphic effects of prenatal treatment with dexamethasone
Wallensteen, L., Zimmermann, M., Thomsen Sandberg, M., Gezelius, A., Nordenström, A., Hirvikoski, T., & Lajic, S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1543 · Cited by 67
Self-citationJanzen, N., Sander, S., Terhardt, M., Steuerwald, U., Peter, M., Das, A. M., & Sander, J. (2011) · Steroids · doi:10.1016/j.steroids.2011.07.013 · Cited by 66
Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations
Hindmarsh, P. C., & Charmandari, E. (2015) · Clinical Endocrinology · doi:10.1111/cen.12653 · Cited by 66
Nordenström, A., Ahmed, S., Jones, J., Coleman, M., Price, D. A., Clayton, P. E., & Hall, C. M. (2005) · Hormone Research in Paediatrics · doi:10.1159/000082896 · Cited by 66
Self-citationKing, T. F. J., Lee, M. C., Williamson, E. E. J., & Conway, G. S. (2016) · Clinical Endocrinology · doi:10.1111/cen.13001 · Cited by 66
Nermoen, I., & Falhammar, H. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0058 · Cited by 66
Self-citationAuchus, R., Witchel, S., Leight, K., Aisenberg, J., Azziz, R., Bachega, T., Baker, L., Baratz, A., Baskin, L., Berenbaum, S., et al. (2010) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2010-275213 · Cited by 66
Self-citationInterventions for hirsutism (excluding laser and photoepilation therapy alone)
van Zuuren, E. J., Fedorowicz, Z., Carter, B., & Pandis, N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010334.pub2 · Cited by 65
Merke, D. P., Cho, D., Anton Calis, K., Keil, M. F., & Chrousos, G. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7275 · Cited by 65
Self-citationNewborn screening for congenital adrenal hyperplasia in New Zealand, 1994-2013
Heather, N. L., Seneviratne, S. N., Webster, D., Derraik, J. G. B., Jefferies, C., Carll, J., Jiang, Y., Cutfield, W. S., & Hofman, P. L. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3168 · Cited by 65
Management considerations for the adult with congenital adrenal hyperplasia
Auchus, R. J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.039 · Cited by 65
Self-citationDriscoll, K. A., Johnson, S. B., Barker, D., Quittner, A. L., Deeb, L. C., Geller, D. E., Gondor, M., & Silverstein, J. H. (2010) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsp138 · Cited by 65
Ruiz-Babot, G., Balyura, M., Hadjidemetriou, I., Ajodha, S. J., Taylor, D. R., Ghataore, L., Taylor, N. F., Schubert, U., Ziegler, C. G., Storr, H. L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.003 · Cited by 65
Self-citationIncreased Infection Risk in Addison’s Disease and Congenital Adrenal Hyperplasia
Tresoldi, A. S., Sumilo, D., Perrins, M., Toulis, K. A., Prete, A., Reddy, N., Wass, J. A. H., Arlt, W., & Nirantharakumar, K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz006 · Cited by 65
Self-citationHirschberg, A. L., Gidlöf, S., Falhammar, H., Frisén, L., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa801 · Cited by 65
Self-citationAn update on prenatal diagnosis and treatment of congenital adrenal hyperplasia
Abraham, M., Yuen, T., Lekarev, O., & New, M. (2012) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1324723 · Cited by 64
Stigma Associated with Classical Congenital Adrenal Hyperplasia in Women’s Sexual Lives
Meyer‐Bahlburg, H. F. L., Khuri, J., Reyes‐Portillo, J. A., Ehrhardt, A. Α., & New, M. I. (2017) · Archives of Sexual Behavior · doi:10.1007/s10508-017-1003-8 · Cited by 64
Neumann, U., Whitaker, M. J., Wiegand, S., Krude, H., Porter, J., Davies, M., Digweed, D., Voet, B., Ross, R. J., & Blankenstein, O. (2018) · Clinical Endocrinology · doi:10.1111/cen.13447 · Cited by 64
Interventions for female pattern hair loss
van Zuuren, E. J., Fedorowicz, Z., Carter, B., Andriolo, R. B., & Schoones, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007628.pub3 · Cited by 64
Nimkarn, S., Lin-Su, K., Berglind, N., Wilson, R. C., & New, M. I. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0964 · Cited by 63
Friães, A., Rêgo, A. T., Aragüés, J. M., Moura, L. F., Mirante, A., Mascarenhas, M. R., Kay, T. T., Lopes, L. A., Rodrigues, J. C., Guerra, S., et al. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.11.015 · Cited by 63
Falhammar, H., & Torpy, D. J. (2016) · Endocrine Practice · doi:10.4158/ep151085.ra · Cited by 63
Self-citationTesticular Adrenal Rest Tumors in Boys and Young Adults with Congenital Adrenal Hyperplasia
Kim, M. S., Goodarzian, F., Keenan, M. F., Geffner, M. E., Koppin, C. M., De Filippo, R. E., & Kokorowski, P. J. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.09.072 · Cited by 63
Cases of congenital adrenal hyperplasia missed by newborn screening in Minnesota
Sarafoglou, K., Banks, K., Kyllo, J., Pittock, S., & Thomas, W. (2012) · JAMA · doi:10.1001/jama.2012.5281 · Cited by 62
Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls
Varness, T. S., Allen, D. B., & Hoffman, G. L. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.04.035 · Cited by 61
Christiansen, P., Mølgaard, C., & Müller, J. (2004) · Hormone Research in Paediatrics · doi:10.1159/000075588 · Cited by 61
Therapeutic management of adrenal insufficiency
Hahner, S., & Allolio, B. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.009 · Cited by 61
Congenital adrenal hyperplasia patient perception of ‘disorders of sex development’ nomenclature
Lin-Su, K., Lekarev, O., Poppas, D. P., & Vogiatzi, M. G. (2015) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-015-0004-4 · Cited by 61
Turcu, A. F., Spencer-Segal, J. L., Farber, R. H., Luo, R., Grigoriadis, D. E., Ramm, C. A., Madrigal, D., Muth, T., O'Brien, C. F., & Auchus, R. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3574 · Cited by 61
Self-citationCognitive impairment in adolescents and adults with congenital adrenal hyperplasia
Karlsson, L., Gezelius, A., Nordenström, A., Hirvikoski, T., & Lajic, S. (2017) · Clinical Endocrinology · doi:10.1111/cen.13441 · Cited by 61
Self-citationTenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome
Miller, W. L., & Merke, D. P. (2018) · Hormone Research in Paediatrics · doi:10.1159/000481911 · Cited by 61
Self-citationGatelais, F., Berthelot, J., Beringue, F., Descamps, P., Bonneau, D., Limal, J.-M., & Coutant, R. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000142733.50918.6e · Cited by 60
Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency
Donaldson, M. D., Thomas, P. H., Love, J. G., Murray, G. D., McNinch, A. W., & Savage, D. C. (1994) · Archives of Disease in Childhood · doi:10.1136/adc.70.3.214 · Cited by 60
Odenwald, B., Nennstiel-Ratzel, U., Dörr, H.-G., Schmidt, H., Wildner, M., & Bonfig, W. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0775 · Cited by 60
Falhammar, H., Frisén, L., Norrby, C., Almqvist, C., Hirschberg, A. L., Nordenskjöld, A., & Nordenström, A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01139 · Cited by 60
Self-citationPeng, Y., Shinde, D. N., Valencia, C. A., Mo, J.-S., Rosenfeld, J., Truitt Cho, M., Chamberlin, A., Li, Z., Liu, J., Gui, B., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx377 · Cited by 60
Bilateral Adrenalectomy in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
MacKay, D., Nordenström, A., & Falhammar, H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00217 · Cited by 59
Self-citationRangaswamaiah, S., Gangathimmaiah, V., Nordenstrom, A., & Falhammar, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00493 · Cited by 59
Self-citationNordenström, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.5.1505 · Cited by 59
Self-citationClassic congenital adrenal hyperplasia and its impact on reproduction
Gomes, L. G., Bachega, T. A. S. S., & Mendonca, B. B. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.037 · Cited by 58
Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia
Ng, S. M., Stępień, K. M., & Krishan, A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012517.pub2 · Cited by 58
Al Hosani, H., Salah, M., Osman, H. M., Farag, H. M., El Assiouty, L., Saade, D., & Hertecant, J. (2014) · Eastern Mediterranean Health Journal · doi:10.26719/2014.20.1.17 · Cited by 57
German, A., Suraiya, S., Tenenbaum-Rakover, Y., Koren, I., Pillar, G., & Hochberg, Z. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0519 · Cited by 57
Livadas, S., & Bothou, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00366 · Cited by 57
Familial male pseudohermaphroditism due to 5-alpha-reductase deficiency in a Turkish village
Akgun, S., Ertel, N. H., Imperato-Mcginley, J., Sayli, B. S., & Shackleton, C. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90262-7 · Cited by 57
Bougneres, P. F., Bouvattier, C. M., Cartigny, M., & Michala, L. (2017) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-016-0040-8 · Cited by 57
Attitudes towards “disorders of sex development” nomenclature among affected individuals
Johnson, E. K., Rosoklija, I., Finlayson, C. A., Chen, D., Yerkes, E. B., Madonna, M. B., Holl, J. L., Baratz, A. B., Davis, G., & Cheng, E. Y. (2017) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2017.03.035 · Cited by 56
Quality of compounded hydrocortisone capsules used in the treatment of children
Neumann, U., Burau, D., Spielmann, S., Whitaker, M. J., Ross, R. J., Kloft, C., & Blankenstein, O. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0248 · Cited by 56
Applying the Female Sexual Functioning Index to Sexual Minority Women
Boehmer, U., Timm, A., Ozonoff, A., & Potter, J. E. (2011) · Journal of Women s Health · doi:10.1089/jwh.2011.3072 · Cited by 56
Kelly, S., McKenna, T., & Young, L. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1810355 · Cited by 56
Ishii, T., Tajima, T., Kashimada, K., Mukai, T., Tanahashi, Y., Katsumata, N., Kanno, J., Hamajima, T., Miyako, K., Ida, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa557 · Cited by 56
Saedi, S. A., Dean, H., Dent, W., Stockl, E., & Cronin, C. (1996) · PEDIATRICS · doi:10.1542/peds.97.1.100 · Cited by 55
Loidi, L., Quinteiro, C., Parajes, S., Barreiro, J., Lestón, D. G., Cabezas‐Agrícola, J. M., Sueiro, A. M., Araujo‐Vilar, D., Catro‐Feijóo, L., Costas, J., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02465.x · Cited by 55
Seo, J. Y., Park, H.-D., Kim, J. W., Oh, H. J., Yang, J. S., Chang, Y. S., Park, W. S., & Lee, S.-Y. (2014) · jpme · doi:10.1515/jpm-2013-0154 · Cited by 55
Meyer‐Bahlburg, H. F. L., Khuri, J., Reyes‐Portillo, J. A., & New, M. I. (2016) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsw034 · Cited by 55
Wijesuriya, S. D., Zhang, G., Dardis, A., & Miller, W. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38097 · Cited by 54
Self-citationMullis, P. E., Hindmarsh, P. C., & Brook, C. G. D. (1990) · European Journal of Pediatrics · doi:10.1007/bf01959473 · Cited by 53
Congenital adrenal hyperplasia – pharmacologic interventions from the prenatal phase to adulthood
Claahsen-van der Grinten, H. L., Stikkelbroeck, N. M. M. L., Otten, B. J., & Hermus, A. R. M. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.004 · Cited by 53
Self-citationLee, P. A., & Houk, C. P. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/982025 · Cited by 53
El‐Maouche, D., Collier, S., Prasad, M., Reynolds, J. C., & Merke, D. P. (2015) · Clinical Endocrinology · doi:10.1111/cen.12507 · Cited by 53
Self-citationOntogeny of adrenal steroid biosynthesis: why girls will be girls
White, P. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28296 · Cited by 53
Debono, M., Mallappa, A., Gounden, V., Nella, A. A., Harrison, R. F., Crutchfield, C. A., Backlund, P. S., Soldin, S. J., Ross, R. J., & Merke, D. P. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0064 · Cited by 53
Self-citationPofi, R., Prete, A., Thornton-Jones, V., Bryce, J., Ali, S. R., Faisal Ahmed, S., Balsamo, A., Baronio, F., Cannuccia, A., Guven, A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz055 · Cited by 53
Self-citationPaizoni, L., Auer, M. K., Schmidt, H., Hübner, A., Bidlingmaier, M., & Reisch, N. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105540 · Cited by 53
Self-citationThe relationship between maternal corticosteroid use and orofacial clefts-a meta-analysis
Xiao, W., Liu, X.-Y., Liu, Y.-S., et al. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2017.02.006 · Cited by 53
The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency
Gomes, L. G., Huang, N., Agrawal, V., Mendonça, B. B., Bachega, T. A. S. S., & Miller, W. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0304 · Cited by 52
Self-citationNordenström, A., Marcus, C., Axelson, M., Wedell, A., & Ritzén, E. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5584 · Cited by 52
Self-citationKösel, S., Burggraf, S., Fingerhut, R., Dörr, H. G., Roscher, A. A., & Olgemöller, B. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.042416 · Cited by 52
Non-classic congenital adrenal hyperplasia
Witchel, S. F. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.010 · Cited by 52
Hayashi, G. Y., Carvalho, D. F., de Miranda, M. C., Faure, C., Vallejos, C., Brito, V. N., Rodrigues, A. D. S., Madureira, G., Mendonca, B. B., & Bachega, T. A. S. S. (2017) · Clinical Endocrinology · doi:10.1111/cen.13292 · Cited by 52
Kocova, M., Janevska, V., & Anastasovska, V. (2018) · Endocrine Connections · doi:10.1530/ec-18-0097 · Cited by 51
Disorders of Sex Development Peer Support
Baratz, A. B., Sharp, M. K., & Sandberg, D. E. (2014) · Endocrine Development · doi:10.1159/000363634 · Cited by 51
Self-citationDing, L., Murphy, M. B., He, Y., Xu, Y., Yeung, L. W. Y., Wang, J., Zhou, B., Lam, P. K. S., Wu, R. S. S., & Giesy, J. P. (2007) · Environmental Toxicology and Chemistry · doi:10.1897/06-388r1.1 · Cited by 51
Arisaka, O., Hoshi, M., Kanazawa, S., Numata, M., Nakajima, D., Kanno, S., Negishi, M., Nishikura, K., Nitta, A., Imataka, M., et al. (2001) · Metabolism · doi:10.1053/meta.2001.21678 · Cited by 50
Hirvikoski, T., Lindholm, T., Lajic, S., & Nordenström, A. (2011) · Acta Paediatrica · doi:10.1111/j.1651-2227.2011.02260.x · Cited by 49
Self-citationBird, I. M., Mason, J. I., & Rainey, W. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4825 · Cited by 49
Determination of a steroid profile in heel prick blood using LC-MS/MS
Boelen, A., Ruiter, A. F., Claahsen-van der Grinten, H. L., Endert, E., & Ackermans, M. T. (2016) · Bioanalysis · doi:10.4155/bio.16.6 · Cited by 49
Hidden morbidity in pediatric primary care
Bernal, P. (2003) · Pediatric Annals · doi:10.3928/0090-4481-20030601-10 · Cited by 49
Webb, E. A., Elliott, L., Carlin, D., Wilson, M., Hall, K., Netherton, J., Reed, J., Barrett, T. G., Salwani, V., Clayden, J. D., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01481 · Cited by 49
Self-citationBurckhardt, M.-A., Udhane, S. S., Marti, N., Schnyder, I., Tapia, C., Nielsen, J. E., Mullis, P. E., Rajpert-De Meyts, E., & Flück, C. E. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0599 · Cited by 49
Self-citationWenzel, J., Grabinski, N., Knopp, C. A., Dendorfer, A., Ramanjaneya, M., Randeva, H. S., Ehrhart-Bornstein, M., Dominiak, P., & Jöhren, O. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.91034.2008 · Cited by 49
Psychoendocrinology of Congenital Adrenal Hyperplasia
Meyer-Bahlburg, H. F. L. (2014) · Genetic Steroid Disorders · doi:10.1016/b978-0-12-416006-4.00023-5 · Cited by 48
Mouritsen, A., Jørgensen, N., Main, K. M., Schwartz, M., & Juul, A. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2009.00967.x · Cited by 48
Crocker, M. K., Barak, S., Millo, C. M., Beall, S. A., Niyyati, M., Chang, R., Avila, N. A., Van Ryzin, C., Segars, J., Quezado, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2298 · Cited by 48
Self-citationvan der Zwan, Y. G., Janssen, E. H. C. C., Callens, N., Wolffenbuttel, K. P., Cohen-Kettenis, P. T., van den Berg, M., Drop, S. L. S., Dessens, A. B., & Beerendonk, C. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12028 · Cited by 48
Tsuji, A., Konishi, K., Hasegawa, S., Anazawa, A., Onishi, T., Ono, M., Morio, T., Kitagawa, T., & Kashimada, K. (2015) · BMC Pediatrics · doi:10.1186/s12887-015-0529-y · Cited by 48
Hines, M. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.07.018 · Cited by 48
Congenital Adrenal Hyperplasia: Classification of Studies Employing Psychological Endpoints
Stout, S. A., Litvak, M., Robbins, N. M., & Sandberg, D. E. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/191520 · Cited by 48
Self-citationBode, H. H., Rivkees, S. A., Cowley, D. M., Pardy, K., & Johnson, S. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70413-0 · Cited by 47
de Almeida Freire, P. O., de Lemos-Marini, S. H. V., Maciel-Guerra, A. T., Morcillo, A. M., Matias Baptista, M. T., de Mello, M. P., & Guerra Jr., G. (2003) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-003-0434-6 · Cited by 47
Tee, M. K., Babalola, G. O., Aza-Blanc, P., Speek, M., Gitelman, S. E., & Miller, W. L. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.11.2109 · Cited by 47
Self-citationPregnancy in women with nonclassic congenital adrenal hyperplasia: time to conceive and outcome
Eyal, O., Ayalon‐Dangur, I., Segev‐Becker, A., Schachter‐Davidov, A., Israel, S., & Weintrob, N. (2017) · Clinical Endocrinology · doi:10.1111/cen.13429 · Cited by 47
Forest, M. G., & Dörr, H. G. (2003) · The Endocrinologist · doi:10.1097/01.ten.0000081690.21823.af · Cited by 47
Kreukels, B. P. C., Cohen-Kettenis, P. T., Roehle, R., van de Grift, T. C., Slowikowska-Hilczer, J., Claahsen-van der Grinten, H., Lindén Hirschberg, A., de Vries, A. L. C., Reisch, N., Bouvattier, C., et al. (2019) · Journal of Sex & Marital Therapy · doi:10.1080/0092623x.2019.1610123 · Cited by 47
Self-citationBaş, F., Kayserili, H., Darendeliler, F., Uyguner, O., Günöz, H., Yüksel Apak, M., Atalar, F., Bundak, R., Wilson, R. C., New, M. I., et al. (2011) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4008/jcrpe.v1i3.49 · Cited by 47
Sasano, H., White, P. C., New, M. I., & Sasano, N. (1988) · Human Pathology · doi:10.1016/s0046-8177(88)80346-0 · Cited by 47
Self-citationCongenital adrenal hyperplasia and the second newborn screen
Chan, C. L., McFann, K., Taylor, L., Wright, D., Zeitler, P. S., & Barker, J. M. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.01.002 · Cited by 46
Bachelot, A., Golmard, J. L., Dulon, J., Dahmoune, N., Leban, M., Bouvattier, C., Cabrol, S., Leger, J., Polak, M., & Touraine, P. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0978 · Cited by 46
Self-citationA Noncategorical Approach to the Psychosocial Care of Persons with DSD and Their Families
Sandberg, D. E., & Mazur, T. (2013) · Focus on sexuality research · doi:10.1007/978-1-4614-7441-8_5 · Cited by 45
Self-citationZimmermann, A., Sido, P. G., Schulze, E., Al Khzouz, C., Lazea, C., Coldea, C., & Weber, M. M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03518.x · Cited by 45
Schaeffer, T. L., Tryggestad, J. B., Mallappa, A., Hanna, A., Krishnan, S., Chernausek, S. D., Chalmers, L. J., Reiner, W. G., Kropp, B. P., & Wisniewski, A. B. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/692439 · Cited by 45
Daae, E., Feragen, K. B., Nermoen, I., & Falhammar, H. (2018) · Endocrine · doi:10.1007/s12020-018-1723-0 · Cited by 45
Self-citationCortisol response to operative stress with anesthesia in healthy children
Taylor, L. K., Auchus, R. J., Baskin, L. S., & Miller, W. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2148 · Cited by 44
Self-citationCongenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states
Held, P. K., Shapira, S. K., Hinton, C. F., Jones, E., Hannon, W. H., & Ojodu, J. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.08.004 · Cited by 44
Bacila, I., Adaway, J., Hawley, J., Mahdi, S., Krone, R., Patel, L., Alvi, S., Randell, T., Gevers, E., Dattani, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00031 · Cited by 44
Self-citationBothou, C., Anand, G., Li, D., Kienitz, T., Seejore, K., Simeoli, C., Ebbehoj, A., Ward, E. G., Paragliola, R. M., Ferrigno, R., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa266 · Cited by 44
Self-citationFalhammar, H., Nyström, H. F., & Thorén, M. C. (2014) · Endocrine · doi:10.1007/s12020-013-0161-2 · Cited by 43
Self-citationMaryniak, A., Ginalska-Malinowska, M., Bielawska, A., & Ondruch, A. (2014) · Child Neuropsychology · doi:10.1080/09297049.2012.745495 · Cited by 43
Hu, M.-C., & Chung, B.-C. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-6-893 · Cited by 43
Nermoen, I., Brønstad, I., Fougner, K. J., Svartberg, J., Øksnes, M., Husebye, E. S., & Løvås, K. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0196 · Cited by 43
Engels, M., Pijnenburg-Kleizen, K. J., Utari, A., Faradz, S. M. H., Oude-Alink, S., van Herwaarden, A. E., Span, P. N., Sweep, F. C., & Claahsen-van der Grinten, H. L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00547 · Cited by 43
Dean, B., Chrisp, G. L., Quartararo, M., Maguire, A. M., Hameed, S., King, B. R., Munns, C. F., Torpy, D. J., Falhammar, H., & Rushworth, R. L. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz255 · Cited by 43
Self-citationDreger, A., Feder, E. K., & Tamar-Mattis, A. (2012) · Journal of Bioethical Inquiry · doi:10.1007/s11673-012-9384-9 · Cited by 43
Wang, C., Pallan, P. S., Zhang, W., Lei, L., Yoshimoto, F. K., Waterman, M. R., Egli, M., & Guengerich, F. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.792465 · Cited by 43
Ilg, L., Kirschbaum, C., Li, S.-C., Rosenlöcher, F., Miller, R., & Alexander, N. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01566 · Cited by 43
Claahsen-van der Grinten, H. L., Noordam, K., Borm, G. F., & Otten, B. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1701 · Cited by 42
17β-Hydroxysteroid dehydrogenases: physiological roles in health and disease
Moghrabi, N., & Andersson, S. (1998) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(98)00066-6 · Cited by 42
Araujo, R. S., Billerbeck, A. E. C., Madureira, G., Mendonca, B. B., & Bachega, T. A. S. S. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02184.x · Cited by 42
Nordenström, A. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32834810a4 · Cited by 42
Self-citationGender development in Indonesian children, adolescents, and adults with disorders of sex development
Ediati, A., Juniarto, A. Z., Birnie, E., Drop, S. L. S., Faradz, S. M. H., & Dessens, A. B. (2015) · Archives of Sexual Behavior · doi:10.1007/s10508-015-0493-5 · Cited by 42
Ceccato, F., Barbot, M., Albiger, N., Zilio, M., De Toni, P., Luisetto, G., Zaninotto, M., Greggio, N. A., Boscaro, M., Scaroni, C., et al. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0104 · Cited by 42
Markmann, S., De, B. P., Reid, J., Jose, C. L., Rosenberg, J. B., Leopold, P. L., Kaminsky, S. M., Sondhi, D., Pagovich, O., & Crystal, R. G. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.203 · Cited by 42
Mental Health in the United States
F., C. B. (1962) · American Journal of Psychiatry · doi:10.1176/ajp.119.6.597-a · Cited by 42
Ediati, A., Faradz, S. M. H., Juniarto, A. Z., van der Ende, J., Drop, S. L. S., & Dessens, A. B. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.12.007 · Cited by 42
Sociocultural aspects of disorders of sex development
Ediati, A., Maharani, N., & Utari, A. (2016) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.21144 · Cited by 42
Self-citationGhizzoni, L., Cappa, M., Vottero, A., Ubertini, G., Carta, D., Di Iorgi, N., Gasco, V., Marchesi, M., Raggi, V., Ibba, A., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0119 · Cited by 41
CM, J., A, M., N, R., N, N., N, K., BA, H., DM, O., MJ, W., JW, T., KH, S., et al. (2018) · Yearbook of Paediatric Endocrinology · doi:10.1530/ey.15.15.5 · Cited by 41
Self-citationMazzilli, R., Stigliano, A., Delfino, M., Olana, S., Zamponi, V., Iorio, C., Defeudis, G., Cimadomo, D., Toscano, V., & Mazzilli, F. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00335 · Cited by 41
Herting, M. M., Azad, A., Kim, R., Tyszka, J. M., Geffner, M. E., & Kim, M. S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa023 · Cited by 41
Disorders or Differences of Sex Development? Views of Affected Individuals on DSD Terminology
Bennecke, E., Köhler, B., Röhle, R., Thyen, U., Gehrmann, K., Lee, P. A., Nordenström, A., Cohen‐Kettenis, P. T., Bouvattier, C., & Wiesemann, C. (2020) · The Journal of Sex Research · doi:10.1080/00224499.2019.1703130 · Cited by 41
Self-citationShiroishi, T., Sagai, T., Natsuume-Sakai, S., & Moriwaki, K. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.2819 · Cited by 40
Fetal endocrine therapy for congenital adrenal hyperplasia should not be done
Miller, W. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.01.005 · Cited by 40
Self-citationSpeek, M. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.11.1749 · Cited by 40
Naiki, Y., Miyado, M., Horikawa, R., Katsumata, N., Onodera, M., Pang, S., Ogata, T., & Fukami, M. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0112 · Cited by 40
Pode‐Shakked, N., Blau, A., Pode‐Shakked, B., Tiosano, D., Weintrob, N., Eyal, O., Zung, A., Levy‐Khademi, F., Tenenbaum‐Rakover, Y., Zangen, D., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02468 · Cited by 40
Epigenetic Alterations Associated With Early Prenatal Dexamethasone Treatment
Karlsson, L., Barbaro, M., Ewing, E., Gomez-Cabrero, D., & Lajic, S. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2018-00377 · Cited by 40
Gleeson, H. K., Wiley, V., Wilcken, B., Elliott, E., Cowell, C., Thonsett, M., Byrne, G., & Ambler, G. (2008) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.2008.01383.x · Cited by 39
Riehl, G., Reisch, N., Roehle, R., Claahsen van der Grinten, H., Falhammar, H., & Quinkler, M. (2020) · Clinical Endocrinology · doi:10.1111/cen.14149 · Cited by 39
Self-citationAli, S. R., Bryce, J., Haghpanahan, H., Lewsey, J. D., Tan, L. E., Atapattu, N., Birkebaek, N. H., Blankenstein, O., Neumann, U., Balsamo, A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa694 · Cited by 39
Self-citationBláha, L., Hilscherová, K., Mazurová, E., Hecker, M., Jones, P. D., Newsted, J. L., Bradley, P. W., Gracia, T., Ďuriš, Z., Horká, I., et al. (2006) · Environment International · doi:10.1016/j.envint.2006.03.011 · Cited by 39
Feminizing genitoplasties: Where are we now?
de Jesus, L. E. (2018) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2018.03.020 · Cited by 39
de Jesus, L. E., Costa, E. C., & Dekermacher, S. (2019) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2019.01.062 · Cited by 39
Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants
Sarafoglou, K., Gaviglio, A., Hietala, A., Frogner, G., Banks, K., McCann, M., & Thomas, W. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.01.038 · Cited by 38
Yoshimoto, F. K., Zhou, Y., Peng, H.-M., Stidd, D., Yoshimoto, J. A., Sharma, K. K., Matthew, S., & Auchus, R. J. (2012) · Biochemistry · doi:10.1021/bi300895w · Cited by 38
Self-citationMoreira, R. P. P., Gomes, L. G., Mendonca, B. B., & Bachega, T. A. S. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044893 · Cited by 38
Collaer, M. L., Hindmarsh, P. C., Pasterski, V., Fane, B. A., & Hines, M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.11.010 · Cited by 38
Mitotane for 21-hydroxylase deficiency in an infertile man
Bry-Gauillard, H., Cartes, A., & Young, J. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1410041 · Cited by 38
Social stigmatisation in late identified patients with disorders of sex development in Indonesia
Ediati, A., Juniarto, A. Z., Birnie, E., Okkerse, J., Wisniewski, A., Drop, S., Faradz, S. M. H., & Dessens, A. (2017) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2017-000130 · Cited by 38
Congenital adrenal hyperplasia
Dessinioti, C., & Katsambas, A. (2009) · Dermato-Endocrinology · doi:10.4161/derm.1.2.7818 · Cited by 38
New directions for the treatment of adrenal insufficiency
Ruiz-Babot, G., Hadjidemetriou, I., King, P. J., & Guasti, L. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00070 · Cited by 37
Self-citationSilveira, E. L., Santos, Ε. Ρ., Bachega, T. A. S., Nader, I. L., Gross, J. L., & Elnecave, R. H. (2008) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2008.21.5.455 · Cited by 37
Perdomini, M., Dos Santos, C., Goumeaux, C., Blouin, V, & Bougnères, P. (2017) · Gene Therapy · doi:10.1038/gt.2017.10 · Cited by 37
Biallelic mutations in FDXR cause neurodegeneration associated with inflammation
Slone, J., Peng, Y., Chamberlin, A., Harris, B., Kaylor, J., McDonald, M. T., Lemmon, M., El-Dairi, M. A., Tchapyjnikov, D., Gonzalez-Krellwitz, L. A., et al. (2018) · Journal of Human Genetics · doi:10.1038/s10038-018-0515-y · Cited by 37
Ethical Issues in Decision-Making for Infants with Disorders of Sex Development
Kon, A. A. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1547269 · Cited by 37
Gaudl, A., Kratzsch, J., & Ceglarek, U. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105389 · Cited by 37
van’t Westeinde, A., Karlsson, L., Thomsen Sandberg, M., Nordenström, A., Padilla, N., & Lajic, S. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhz274 · Cited by 37
Self-citationFine tuning for quality of life: 21st century approach to treatment of Addison’s disease
Reisch, N., & Arlt, W. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.01.008 · Cited by 36
Self-citationKopacek, C., de Castro, S. M., Prado, M. J., da Silva, C. M. D., Beltrão, L. A., & Spritzer, P. M. (2017) · BMC Pediatrics · doi:10.1186/s12887-016-0772-x · Cited by 36
Beyond Pink and Blue: The Complexity of Early Androgen Effects on Gender Development
Berenbaum, S. A. (2018) · Child Development Perspectives · doi:10.1111/cdep.12261 · Cited by 36
Prenatal genetic testing and treatment for congenital adrenal hyperplasia
Simpson, J. L., & Rechitsky, S. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.041 · Cited by 36
Reisch, N. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0820-2085 · Cited by 36
Self-citationPregnancy in Congenital Adrenal Hyperplasia
Reisch, N. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.05.011 · Cited by 36
Self-citationSpeiser, P., Chawla, R., Chen, M., Diaz-Thomas, A., Finlayson, C., Rutter, M., Sandberg, D., Shimy, K., Talib, R., Cerise, J., et al. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6020037 · Cited by 36
Self-citationSteroid metabolomic disease signature of nonsyndromic childhood obesity
Gawlik, A., Shmoish, M., Hartmann, M. F., Malecka-Tendera, E., Wudy, S. A., & Hochberg, Z. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1754 · Cited by 36
Self-citationMiR-30a targets IL-1α and regulates islet functions as an inflammation buffer and response factor
Jiang, X. J., Xu, C., Fan, L., Liao, M., Wang, W., Xu, N., Zhang, Y., & Xie, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-05560-1 · Cited by 36
Pijnenburg-Kleizen, K. J., Engels, M., Mooij, C. F., Griffin, A., Krone, N., Span, P. N., van Herwaarden, A. E., Sweep, F. C. G. J., & Claahsen-van der Grinten, H. L. (2015) · Endocrinology · doi:10.1210/en.2015-1087 · Cited by 35
Barillas, J. E., Eichner, D., Van Wagoner, R., & Speiser, P. W. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01595 · Cited by 35
Self-citationSonography and magnetic resonance imaging characteristics of testicular adrenal rest tumors
Yılmaz, R., Şahin, D., Aghayev, A., Erol, O. B., Poyrazoğlu, Ş., Saka, N., & Yekeler, E. (2018) · Polish Journal of Radiology · doi:10.12659/pjr.901986 · Cited by 35
Pijnenburg-Kleizen, K. J., Thomas, C. M. G., Otten, B. J., Roeleveld, N., & der Grinten, H. L. C. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0006 · Cited by 35
Self-citationAdrenal steroidogenesis following prenatal dexamethasone exposure in the spiny mouse
Quinn, T. A., Ratnayake, U., Castillo-Melendez, M., Moritz, K. M., Dickinson, H., & Walker, D. W. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0514 · Cited by 34
Kamrath, C., Hartmann, M. F., Boettcher, C., Zimmer, K.-P., & Wudy, S. A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.10.013 · Cited by 34
Self-citationThe status of neonatal screening in China, 2013
Zhong, K., Wang, W., He, F., & Wang, Z. (2016) · Journal of Medical Screening · doi:10.1177/0969141315597715 · Cited by 34
Current and future perspective of newborn screening: an Indian scenario
Kaur, G., Thakur, K., Kataria, S., Singh, T. R., Chavan, B. S., Kaur, G., & Atwal, R. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0009 · Cited by 34
Melin, J., Parra-Guillen, Z. P., Michelet, R., Truong, T., Huisinga, W., Hartung, N., Hindmarsh, P., & Kloft, C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa071 · Cited by 34
A Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia
El-Maouche, D., Merke, D. P., Vogiatzi, M. G., Chang, A. Y., Turcu, A. F., Joyal, E. G., Lin, V. H., Weintraub, L., Plaunt, M. R., Mohideen, P., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa381 · Cited by 34
Self-citationImproda, N., Barbieri, F., Ciccarelli, G. P., Capalbo, D., & Salerno, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00212 · Cited by 34
van’t Westeinde, A., Karlsson, L., Nordenström, A., Padilla, N., & Lajic, S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa340 · Cited by 34
Self-citationAdult height of subjects with nonclassical 21-hydroxylase deficiency
Eyal, O., Tenenbaum‐Rakover, Y., Shalitin, S., Israel, S., & Weintrob, N. (2013) · Acta Paediatrica · doi:10.1111/apa.12147 · Cited by 33
Cognitive function in children with classic congenital adrenal hyperplasia
Hamed, S. A., Metwalley, K. A., & Farghaly, H. S. (2018) · European Journal of Pediatrics · doi:10.1007/s00431-018-3226-7 · Cited by 33
Turcu, A. F., El-Maouche, D., Zhao, L., Nanba, A. T., Gaynor, A., Veeraraghavan, P., Auchus, R. J., & Merke, D. P. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0129 · Cited by 33
Auer, M. K., Paizoni, L., Hofbauer, L. C., Rauner, M., Chen, Y., Schmidt, H., Huebner, A., Bidlingmaier, M., & Reisch, N. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105734 · Cited by 33
Self-citationImmature adrenal steroidogenesis in preterm infants
Nomura, S. (1997) · Early Human Development · doi:10.1016/s0378-3782(97)00037-6 · Cited by 32
Research works printed but not linked: 2
- McCann-Crosby, 2014, Non classic CAH; targets of treatment and transition, Pediatr Endocr Rev., 12, 224
- Auchus, 2012, Abiraterone acetate added to physiologic hydrocortisone dosing safely controls androgen excess in adult women with classical 21-hydroxylase deficiency, Endocr Rev., 33, SUN-LB2
Cited by
Overview of the 2022 WHO Classification of Adrenal Cortical Tumors
Mete, O., Erickson, L. A., Juhlin, C. C., de Krijger, R. R., Sasano, H., Volante, M., & Papotti, M. G. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09710-8 · Cited by 343
Clinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae050 · Cited by 224
Self-citationManagement challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Self-citationGlucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations
Alcubierre, D. D., Ferrari, D., Mauro, G. C. D., Isidori, A. M., Tomlinson, J., & Pofi, R. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02091-7 · Cited by 77
“In the most severe Salt-Wasting (SW-CAH) form, there is little or no residual enzyme activity, whereas patients with the Simple-Virilizing (SV-CAH) form still retain 1–5% enzyme activity [153].”
BackgroundPhase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia
Auchus, R. J., Hamidi, O., Pivonello, R., Bancos, I., Russo, G., Witchel, S. F., Isidori, A. M., Rodien, P., Srirangalingam, U., Kiefer, F. W., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2404656 · Cited by 79
Self-citation
Metadata
- Authors
- Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., Krone, N., Merke, D. P., Miller, W. L., Nordenström, A., Reisch, N., Sandberg, D. E., Stikkelbroeck, N. M. M. L., Touraine, P., Utari, A., Wudy, S. A., & White, P. C.
- Affiliations
- Department of Pediatric Endocrinology, Radboud University Medical Centre, Amalia Childrens Hospital, Nijmegen, The Netherlands
- Northwell Health (US)
- University of Glasgow (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of Michigan (US)
- Karolinska University Hospital (SE)
- University of Bern (CH)
- Queen Mary University of London (GB)
- Technische Universität Dresden (DE)
- Radboud University Medical Center (NL)
- University Hospital Carl Gustav Carus (DE)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
- University of California, San Francisco (US)
- LMU Klinikum (DE)
- Sorbonne Université (FR)
- Diponegoro University (ID)
- Justus-Liebig-Universität Gießen (DE)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- White, Perrin C
- ORCID
- Claahsen - van der Grinten, Hedi L
- Speiser, Phyllis W
- Ahmed, S Faisal
- Arlt, Wiebke
- Auchus, Richard J
- Falhammar, Henrik
- Flück, Christa E
- Guasti, Leonardo
- Huebner, Angela
- Krone, Nils
- Merke, Deborah P
- Miller, Walter L
- Nordenström, Anna
- Reisch, Nicole
- Sandberg, David E
- Touraine, Philippe
- Utari, Agustini
- Wudy, Stefan A
- White, Perrin C
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2021-05-07
- Volume
- 43
- Issue
- 1
- Pages
- 91-159
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W4229036110
- Semantic Scholar
- 1867a4639fab9f23f14102ccc6107c07963e64dc
- Cited by
- 556
- References
- 831
- Citations by year
- 2026: 102 · 2025: 125 · 2024: 149 · 2023: 97 · 2022: 68 · 2021: 14
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Endocrine Reviews (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (U01-HD083493)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, CYP21A2 mutations, cortisol production, steroidogenic pathway, newborn screening, steroid profiling, genotyping, cell therapy, gene therapy, long-term outcomes, disease registries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.